BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33767984)

  • 1. Whole-Tumor Histogram and Texture Imaging Features on Magnetic Resonance Imaging Combined With Epstein-Barr Virus Status to Predict Disease Progression in Patients With Nasopharyngeal Carcinoma.
    Li Q; Wang T; Huang Y; Li Q; Liu P; Grimm R; Fu C; Zhang Y; Gu Y
    Front Oncol; 2021; 11():610804. PubMed ID: 33767984
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
    Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
    Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma.
    Mao J; Fang J; Duan X; Yang Z; Cao M; Zhang F; Lu L; Zhang X; Wu X; Ding Y; Shen J
    Eur Radiol; 2019 Aug; 29(8):4105-4113. PubMed ID: 30617473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogram analysis of quantitative parameters from synthetic MRI: correlations with prognostic factors in nasopharyngeal carcinoma.
    Yang F; Li X; Li Y; Lei H; Du Q; Yu X; Li L; Zhao Y; Xie L; Lin M
    Eur Radiol; 2023 Aug; 33(8):5344-5354. PubMed ID: 37036478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
    Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC
    Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
    Sriyook A; Lertbutsayanukul C; Jittapiromsak N
    Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment
    Lin HC; Chan SC; Cheng NM; Liao CT; Hsu CL; Wang HM; Lin CY; Chang JT; Ng SH; Yang LY; Yen TC
    Oral Oncol; 2020 May; 104():104628. PubMed ID: 32163890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
    Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
    Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
    Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between nasopharyngeal carcinoma and lymphoma at the primary site using whole-tumor histogram analysis of apparent diffusion coefficient maps.
    Lian S; Zhang C; Chi J; Huang Y; Shi F; Xie C
    Radiol Med; 2020 Jul; 125(7):647-653. PubMed ID: 32072391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histogram analysis of diffusion kurtosis imaging of nasopharyngeal carcinoma: Correlation between quantitative parameters and clinical stage.
    Xu XQ; Ma G; Wang YJ; Hu H; Su GY; Shi HB; Wu FY
    Oncotarget; 2017 Jul; 8(29):47230-47238. PubMed ID: 28525383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging based on radiomics for differentiating T1-category nasopharyngeal carcinoma from nasopharyngeal lymphoid hyperplasia: a multicenter study.
    Cheng J; Su W; Wang Y; Zhan Y; Wang Y; Yan S; Yuan Y; Chen L; Wei Z; Zhang S; Gao X; Tang Z
    Jpn J Radiol; 2024 Feb; ():. PubMed ID: 38409300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-based radiomics as response predictor to radiochemotherapy for metastatic cervical lymph node in nasopharyngeal carcinoma.
    Xu H; Liu J; Huang Y; Zhou P; Ren J
    Br J Radiol; 2021 Jun; 94(1122):20201212. PubMed ID: 33882240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
    Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
    J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
    Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
    Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
    Wu G; Huang W; Xu J; Li W; Wu Y; Yang Q; Liu K; Zhu M; Balasubramanian PS; Li M
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1771-1780. PubMed ID: 34398299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.
    Chan AT; Lo YM; Zee B; Chan LY; Ma BB; Leung SF; Mo F; Lai M; Ho S; Huang DP; Johnson PJ
    J Natl Cancer Inst; 2002 Nov; 94(21):1614-9. PubMed ID: 12419787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
    Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.